Cargando…

Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma

Immunohistochemical, cytochemical and ultrastructural data showing vivid angiogenesis and numerous mast cells (MCs) in the bone marrow of 24 patients with active multiple myeloma (MM) compared with 34 patients with non-active MM and 22 patients with monoclonal gammopathy of undetermined significance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ribatti, D, Vacca, A, Nico, B, Quondamatteo, F, Ria, R, Minischetti, M, Marzullo, A, Herken, R, Roncali, L, Dammacco, F
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362443/ https://www.ncbi.nlm.nih.gov/pubmed/10027312 http://dx.doi.org/10.1038/sj.bjc.6690070

Ejemplares similares

Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas
por: Vacca, A, et al.
Publicado: (1999)

Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas?
por: Ribatti, D, et al.
Publicado: (1998)

Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma
por: Ribatti, D, et al.
Publicado: (2007)

Angiogenesis and Progression in Human Melanoma
por: Ria, R., et al.
Publicado: (2010)

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma
por: Lamanuzzi, Aurelia, et al.
Publicado: (2018)

Mast Cells and Angiogenesis in Human Plasma Cell Malignancies
por: Ribatti, Domenico, et al.
Publicado: (2019)

New Insights in Anti-Angiogenesis in Multiple Myeloma
por: Ribatti, Domenico, et al.
Publicado: (2018)

Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update
por: Ria, Roberto, et al.
Publicado: (2018)

Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients
por: Lamanuzzi, Aurelia, et al.
Publicado: (2016)

Adipocytes, mast cells and angiogenesis
por: Ribatti, Domenico, et al.
Publicado: (2020)

Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma
por: Ria, Roberto, et al.
Publicado: (2020)

Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target?()
por: Saltarella, Ilaria, et al.
Publicado: (2018)

Proteolytic Activity of Human Lymphoid Tumor Cells. Correlation with Tumor Progression
por: Vacca, Angelo, et al.
Publicado: (2000)

HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma
por: Rao, Luigia, et al.
Publicado: (2020)

Controversial role of mast cells in NSCLC tumor progression and angiogenesis
por: Longo, Vito, et al.
Publicado: (2022)

Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma
por: Calcinotto, Arianna, et al.
Publicado: (2015)

Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium
por: Ribatti, Domenico, et al.
Publicado: (2007)

The Effect of Smoking on Mast Cells Density and Angiogenesis in Chronic Periodontitis
por: Jalayer Naderi, Noushin, et al.
Publicado: (2017)

Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma
por: Ribatti, D, et al.
Publicado: (2007)

New therapies in multiple myeloma
por: Merchionne, F., et al.
Publicado: (2007)

A multiple myeloma that progressed as type I cryoglobulinemia with skin ulcers and foot necrosis: A case report
por: Solimando, Antonio G., et al.
Publicado: (2018)

Managing myelodysplastic symptoms in elderly patients
por: Ria, R, et al.
Publicado: (2009)

Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-γ
por: Ribatti, D, et al.
Publicado: (2006)

Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients
por: Cury, Priscilla Cury de Camargo, et al.
Publicado: (2020)

Angiogenesis in myelodysplastic syndromes
por: Pruneri, G, et al.
Publicado: (1999)

Neutropenia and G-CSF in lymphoproliferative diseases
por: Ria, Roberto, et al.
Publicado: (2013)

JunB is a key regulator of multiple myeloma bone marrow angiogenesis
por: Fan, Fengjuan, et al.
Publicado: (2021)

Bcl6/p53 expression, macrophages/mast cells infiltration and microvascular density in invasive breast carcinoma
por: Tamma, Roberto, et al.
Publicado: (2018)

Evaluation of Angiogenesis in Multiple Myeloma by VEGF Immunoexpression and Microvessel Density
por: Palta, Anshu, et al.
Publicado: (2020)

Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies
por: Ria, Roberto, et al.
Publicado: (2014)

Density of human bone marrow stromal cells regulates commitment to vascular lineages
por: Whyte, Jemima L., et al.
Publicado: (2011)

Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin
por: Mangieri, Domenica, et al.
Publicado: (2008)

Mast cells in tumors. First evidence
por: Ribatti, Domenico
Publicado: (2022)

Mast Cells and Resistance to Immunotherapy in Cancer
por: Ribatti, Domenico
Publicado: (2023)

Mouse Bone Marrow-Derived Mast Cells Induce Angiogenesis by Tissue Engineering in Rats: Histological Evidence
por: Karimi, Ali, et al.
Publicado: (2018)

Mast Cells and Interleukins
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

Cancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling
por: Solimando, Antonio Giovanni, et al.
Publicado: (2020)

Hematopoiesis and Mast Cell Development
por: Ribatti, Domenico, et al.
Publicado: (2023)

Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients
por: Ria, Roberto, et al.
Publicado: (2020)

Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin(®) protein MP0250: a preclinical study
por: Rao, Luigia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qo72mrg8bje7e7is2vvo7rgd85